Aldebaran Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,842
| Closed | -$204K | – | 80 |
|
|
2022
Q4 | $204K | Sell |
1,842
-600
| -25% | -$61.3K | 0.22% | 77 |
|
|
2022
Q3 | $211K | Sell |
2,442
-130
| -5% | -$11.6K | 0.23% | 74 |
|
|
2022
Q2 | $233K | Sell |
2,572
-1,500
| -37% | -$133K | 0.25% | 71 |
|
|
2022
Q1 | $334K | Buy |
4,072
+10
| +0.2% | +$788 | 0.26% | 69 |
|
|
2021
Q4 | $311K | Buy |
4,062
+230
| +6% | +$18.3K | 0.23% | 71 |
|
|
2021
Q3 | $288K | Sell |
3,832
-315
| -8% | -$24K | 0.23% | 69 |
|
|
2021
Q2 | $323K | Sell |
4,147
-199
| -5% | -$14.8K | 0.27% | 65 |
|
|
2021
Q1 | $320K | Buy |
4,346
+262
| +6% | +$19.3K | 0.28% | 63 |
|
|
2020
Q4 | $319K | Sell |
4,084
-1,173
| -22% | -$89.7K | 0.3% | 62 |
|
|
2020
Q3 | $416K | Sell |
5,257
-410
| -7% | -$32.1K | 0.43% | 52 |
|
|
2020
Q2 | $418K | Sell |
5,667
-6,017
| -51% | -$453K | 0.49% | 55 |
|
|
2020
Q1 | $858K | Sell |
11,684
-49
| -0.4% | -$3.85K | 0.84% | 43 |
|
|
2019
Q4 | $1.02M | Buy |
11,733
+7
| +0.1% | +$575 | 0.77% | 50 |
|
|
2019
Q3 | $936K | Sell |
11,726
-1,391
| -11% | -$111K | 0.62% | 59 |
|
|
2019
Q2 | $1.05M | Buy |
13,117
+9
| +0.1% | +$689 | 0.72% | 55 |
|
|
2019
Q1 | $1.04M | Buy |
13,108
+65
| +0.5% | +$4.86K | 0.73% | 53 |
|
|
2018
Q4 | $951K | Buy |
13,043
+8
| +0.1% | +$565 | 0.72% | 51 |
|
|
2018
Q3 | $882K | Buy |
13,035
+8
| +0.1% | +$510 | 0.57% | 58 |
|
|
2018
Q2 | $755K | Buy |
13,027
+10
| +0.1% | +$564 | 0.52% | 63 |
|
|
2018
Q1 | $677K | Sell |
13,017
-830
| -6% | -$44.8K | 0.45% | 65 |
|
|
2017
Q4 | $743K | Buy |
13,847
+689
| +5% | +$38.2K | 0.49% | 60 |
|
|
2017
Q3 | $804K | Buy |
13,158
+60
| +0.5% | +$3.64K | 0.55% | 58 |
|
|
2017
Q2 | $801K | Buy |
13,098
+8,235
| +169% | +$501K | 0.58% | 53 |
|
|
2017
Q1 | $295K | Buy |
4,863
+9
| +0.2% | +$546 | 0.22% | 81 |
|
|
2016
Q4 | $273K | Sell |
4,854
-150
| -3% | -$8.78K | 0.22% | 88 |
|
|
2016
Q3 | $298K | Buy |
5,004
+7
| +0.1% | +$409 | 0.24% | 83 |
|
|
2016
Q2 | $283K | Sell |
4,997
-2,696
| -35% | -$143K | 0.23% | 84 |
|
|
2016
Q1 | $388K | Buy |
7,693
+9
| +0.1% | +$441 | 0.34% | 73 |
|
|
2015
Q4 | $385K | Buy |
7,684
+8
| +0.1% | +$403 | 0.36% | 69 |
|
|
2015
Q3 | $362K | Sell |
7,676
-306
| -4% | -$16.3K | 0.34% | 74 |
|
|
2015
Q2 | $434K | Buy |
7,982
+8
| +0.1% | +$449 | 0.37% | 72 |
|
|
2015
Q1 | $437K | Sell |
7,974
-202
| -2% | -$11.4K | 0.37% | 73 |
|
|
2014
Q4 | $443K | Sell |
8,176
-98
| -1% | -$5.46K | 0.39% | 75 |
|
|
2014
Q3 | $468K | Sell |
8,274
-2,403
| -23% | -$135K | 0.42% | 67 |
|
|
2014
Q2 | $589K | Sell |
10,677
-165
| -2% | -$9K | 0.46% | 65 |
|
|
2014
Q1 | $587K | Buy |
10,842
+9
| +0.1% | +$466 | 0.51% | 66 |
|
|
2013
Q4 | $517K | Buy |
+10,833
| New | +$495K | 0.49% | 64 |
|
Other funds holding MRK
Aldebaran Financial's MRK Position: Q1 2023 in Review
Aldebaran Financial sold out of Merck (MRK) in Q1 2023, closing a stake of 1,842 shares — an estimated $204K sold.
Aldebaran Financial first reported a position in MRK in Q4 2013 and held it in 37 quarters. The position peaked at $1.05M in Q2 2019. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.
- Aldebaran Financial reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
- Aldebaran Financial sold 1,842 Merck shares in Q1 2023, an estimated $204K.
- Aldebaran Financial first reported a position in Merck in Q4 2013 and held it in 37 quarters.
- Aldebaran Financial's Merck position peaked at $1.05M in Q2 2019.
- 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.
Based on Aldebaran Financial's 13F filing for Q1 2023, filed 24 Apr 2023.